Frazier Life Sciences Management L.P. Acquires 271,122 Share

Frazier Life Sciences Management L.P. lifted its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 44.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 885,165 shares of the company’s stock after acquiring an additional 271,122 shares during the […]

Related Keywords

Mark Jeffrey Delong , Pascal Deschatelets , Quarter For Apellis Pharmaceuticals , Securities Exchange Commission , Woodward Diversified Capital , News Ratings For Apellis Pharmaceuticals Daily , Nasdaq , Hc Advisors , Apellis Pharmaceuticals Price Performance , Jpmorgan Chase Co , Apellis Pharmaceuticals , Apellis Pharmaceuticals Profile , Citigroup , Covestor Ltd , Frazier Life Sciences Management , Exchange Commission , Apellis Pharmaceuticals Inc , Whittier Trust Co , Asset Management Group , Needham Company , Free Report , Management Group , Diversified Capital , Whittier Trust , Get Free Report , Apellis Pharmaceuticals Daily ,